Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1356)
|
Core Tip (1368)
|
Full Article (HTML) (4485)
|
Full Article (PDF)-777K (702)
|
Audio-357K (37)
|
Peer-Review Report-122K (230)
|
Answering Reviewers-64K (279)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (16)
|
Total Visits (13374)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications
World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1623)
|
Core Tip (1649)
|
Full Article (HTML) (14592)
|
Figures (1-4) (1988)
|
Full Article (PDF)-948K (1412)
|
Audio-1310K (50)
|
Peer-Review Report-106K (471)
|
Answering Reviewers-19K (324)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (68)
|
Total Visits (30617)
|
Similar Articles (524)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model
World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1492)
|
Core Tip (1492)
|
Full Article (HTML) (5437)
|
Figures (1-2) (450)
|
Tables (1-2) (427)
|
Full Article (PDF)-1246K (813)
|
Audio-442K (36)
|
Peer-Review Report-131K (408)
|
Answering Reviewers-120K (254)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (12)
|
Total Visits (20707)
|
Similar Articles (17)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?
World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1375)
|
Core Tip (1380)
|
Full Article (HTML) (4401)
|
Figures (1-3) (457)
|
Tables (1-1) (445)
|
Full Article (PDF)-814K (601)
|
Audio-757K (32)
|
Peer-Review Report-105K (311)
|
Answering Reviewers-109K (282)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (18963)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1446)
|
Core Tip (1476)
|
Full Article (HTML) (4189)
|
Tables (1-3) (444)
|
Full Article (PDF)-799K (560)
|
Audio-1969K (25)
|
Peer-Review Report-132K (284)
|
Answering Reviewers-50K (250)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (16423)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
